Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free CLRB Stock Alerts

Cellectar Biosciences (CLRB) Institutional Ownership

Cellectar Biosciences logo
$3.20 +0.26 (+8.84%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$3.10 -0.10 (-2.97%)
As of 07:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Cellectar Biosciences (NASDAQ:CLRB)

Current
Institutional Ownership
Percentage
16.41%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$472.97K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$3.07M
Get CLRB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cellectar Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CLRB Institutional Buying and Selling by Quarter

Cellectar Biosciences Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/1/2026 Sequoia Financial Advisors LLC18,850$48K0.0%-25.6%0.445%
2/18/2026XTX Topco Ltd12,243$36K0.0%N/A0.289%
2/12/2026 DRW Securities LLC45,190$133K0.0%+114.2%1.066%
2/9/2026Geode Capital Management LLC28,636$84K0.0%+15.0%0.675%
2/3/2026 Sequoia Financial Advisors LLC25,350$75K0.0%+135.1%0.598%
11/17/2025Citadel Advisors LLC18,526$104K0.0%N/A0.580%
11/12/2025 Dimensional Fund Advisors LP13,033$73K0.0%N/A0.408%
10/29/2025 Sequoia Financial Advisors LLC10,783$60K0.0%N/A0.338%
8/13/2025Riverview Capital Advisers LLC10,500$75K0.0%N/A0.580%
8/8/2025Geode Capital Management LLC14,439$103K0.0%-96.7%0.798%
5/12/2025Simplex Trading LLC173,129$54K0.0%+331.3%0.376%
5/8/2025Baader Bank Aktiengesellschaft172,940$55K0.0%N/A0.375%
5/8/2025XTX Topco Ltd104,323$33K0.0%+122.6%0.226%
4/23/2025Sequoia Financial Advisors LLC203,260$64K0.0%+1,301.8%0.441%
2/17/2025Squarepoint Ops LLC520,240$156K0.0%N/A1.129%
2/17/2025Bank of America Corp DE206,783$62K0.0%+25.3%0.449%
2/13/2025ADAR1 Capital Management LLC585,261$175K0.0%-42.7%1.270%
2/12/2025JPMorgan Chase & Co.182,403$55K0.0%+687.3%0.396%
11/19/2024Barclays PLC120,497$258K0.0%-30.0%0.292%
11/16/2024Geode Capital Management LLC352,452$754K0.0%+3.3%0.869%
11/15/2024Barclays PLC120,497$258K0.0%-30.0%0.297%
11/15/2024XTX Topco Ltd53,022$113K0.0%-16.2%0.131%
11/6/2024Oppenheimer & Co. Inc.12,500$27K0.0%N/A0.031%
10/30/2024Rosalind Advisors Inc.3,671,550$7.86M4.9%+35.7%10.241%
10/22/2024Sequoia Financial Advisors LLC23,800$51K0.0%N/A0.066%
8/20/2024Nantahala Capital Management LLC1,833,325$4.58M0.3%-2.1%5.114%
8/16/2024Coastal Bridge Advisors LLC11,000$28K0.0%-31.3%0.031%
8/12/2024XTX Topco Ltd63,304$158K0.0%+432.4%0.177%
8/7/2024AIGH Capital Management LLC3,036,187$7.59M2.4%+8.2%8.469%
7/12/2024Rosalind Advisors Inc.2,705,616$6.76M5.0%+335.4%7.547%
5/10/2024Vanguard Group Inc.1,191,081$4.74M0.0%+146.7%3.322%
4/25/2024Rosalind Advisors Inc.621,478$2.47M2.3%-69.0%1.926%
2/14/2024ADAR1 Capital Management LLC1,378,082$3.82M1.4%N/A11.213%
2/12/2024AIGH Capital Management LLC1,915,220$5.31M2.1%+182.7%15.584%
2/9/2024Worth Venture Partners LLC693,909$1.92M1.0%+148.6%5.646%
1/1/2024Vanguard Group Inc.175,884$464K0.0%+2.3%1.431%
11/15/2023Worth Venture Partners LLC279,123$737K0.4%-11.0%2.808%
11/15/2023Acuta Capital Partners LLC121,300$320K0.2%N/A1.220%
11/13/2023AIGH Capital Management LLC677,511$1.79M0.8%-16.7%6.816%
7/21/20231900 Wealth Management LLC18,000$35K0.0%+50.0%0.185%
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
2/16/2023AIGH Capital Management LLC931,888$1.59M0.5%+434.3%9.924%
11/16/2022Maven Securities LTD25,000$84K0.0%-93.8%0.266%
11/14/2022Worth Venture Partners LLC41,636$140K0.1%-90.9%0.444%
11/14/2022Maven Securities LTD25,000$84K0.0%-93.8%0.266%
11/3/2022ACT Capital Management LLC21,750$73K0.1%-90.0%0.356%
10/31/20221900 Wealth Management LLC12,000$40K0.0%N/A0.196%
5/12/2022AIGH Capital Management LLC1,837,046$1.26M0.3%+104.9%3.007%
4/27/20221900 Wealth Management LLC120,000$83K0.0%+100.0%0.196%
2/14/2022Maven Securities LTD400,000$266K0.0%-60.4%0.655%


CLRB Institutional Ownership - Frequently Asked Questions

During the previous two years, 19 institutional investors and hedge funds held shares of Cellectar Biosciences. The most heavily invested institutionals were Rosalind Advisors Inc. ($7.86M), AIGH Capital Management LLC ($7.59M), Nantahala Capital Management LLC ($4.58M), Barclays PLC ($258K), ADAR1 Capital Management LLC ($175K), Squarepoint Ops LLC ($156K), and DRW Securities LLC ($133K).Learn more on Cellectar Biosciences' institutional investors.

16.41% of Cellectar Biosciences' stock is owned by institutional investors. Learn more on CLRB's institutional investor holdings.

Of the 15 institutional investors that purchased Cellectar Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($3.05M), Squarepoint Ops LLC ($520.24K), Sequoia Financial Advisors LLC ($237.91K), AIGH Capital Management LLC ($231.27K), Baader Bank Aktiengesellschaft ($172.94K), JPMorgan Chase & Co. ($159.23K), and Simplex Trading LLC ($132.99K).

Institutional investors have bought a total of 107,485 shares in the last 24 months. This purchase volume represents approximately $472.97K in transactions.

The following institutional investors have sold Cellectar Biosciences stock in the last 24 months: Geode Capital Management LLC ($428.99K), and Sequoia Financial Advisors LLC ($6.50K).

Institutional investors have sold a total of 435,485 shares in the last 24 months. This volume of shares sold represents approximately $3.07M in transactions.


Related Companies

This page (NASDAQ:CLRB) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel